Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
625.00    0.00 (0.00%)
Bid:
620.00
Ask:
630.00
Spread: 10.00 (1.613%)
Market Cap: £210.14m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Exercise of Share Options

27 Sep 2013 16:24

RNS Number : 1655P
Avingtrans PLC
27 September 2013
 



 

Avingtrans Plc

("Avingtrans" or the "Company" or the "Group")

 

Exercise of Share Options

 

Avingtrans (AIM:AVG), a manufacturer of critical components and associated services to the global aerospace, energy and medical sectors announces that on 26 September 2013 the Company issued 181,667 ordinary shares of 5 pence each ("Ordinary Shares") following the exercise of options under the Company's CSOP share option scheme.

 

Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and it is expected that admission will take place on 2 October 2013. Upon Admission, the shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.

 

After admission of these new shares, the Company's total issued share capital is 27,238,564 Ordinary Shares. Avingtrans does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in Avingtrans is 27,238,564.

 

The above figure 27,238,564 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Avingtrans under the Disclosure and Transparency Rules.

Enquiries:

Avingtrans plc

Steve McQuillan, CEO

Stephen King, CFO 

 

0115 949 9020

Numis Securities LimitedDavid Poutney (Corporate Broking)

Richard Thomas (Corporate Finance and Nominated Adviser)

 

020 7260 1000

Newgate Threadneedle (Financial PR)Josh RoystonHeather Armstrong

020 7653 9850

 

About Avingtrans

 

Avingtrans plc is engaged in the provision of highly engineered components and services to the Aerospace, Energy and Medical markets worldwide.

The business is made up of 2 divisions:

Aerospace, engaged in the manufacture of rigid pipe assemblies, fabrications and prismatic components - both metallic and composite - for the global aerospace market and precision polishing of aircraft components and;

 

Energy and medical, engaged in the manufacture of machined and fabricated pressure and vacuum vessels and components for the energy, medical, science and research communities. Plus, design and manufacture of fabricated poles and cabinets for roadside safety cameras and rail track signalling.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASNXAADDEFF
Date   Source Headline
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results
29th Jun 20217:00 amRNSMetalcraft training school planning go-ahead
2nd Jun 20217:00 amRNSBooth Industries Reincorporates
1st Jun 20217:00 amRNSMetalcraft secures Phase 2 Sellafield box contract
29th Apr 20214:30 pmRNSDirector Shareholdings, Exercise of Options & TVR
13th Apr 20217:00 amRNSExercise of Options and Total Voting Rights
12th Apr 20211:16 pmRNSHolding(s) in Company
9th Apr 20219:59 amRNSHolding(s) in Company
1st Apr 20217:00 amRNSDirector Shareholdings, Exercise of Options & TVR
12th Mar 20217:00 amRNSDisposal of Peter Brotherhood Limited
10th Feb 20217:00 amRNSInterim Results
29th Jan 20217:00 amRNSCompletion of Acquisition
26th Jan 20212:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.